Resolve Biosciences raised €72M in a Series B round in Oct 2022. The company is based in Munich, Germany. Investors in the round: Alafi Capital, EDBI, NRW.BANK and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
